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Abstract
 
Isolated peripheral blood CD4 cells from allergic individuals express CC chemokine receptor
(CCR)3 and CCR4 after expansion in vitro. In addition, human T helper type 2 (Th2) cells po-
larized in vitro selectively express CCR3 and CCR4 at certain stages of activation/differentiation
and respond preferentially to the ligands eotaxin and monocyte-derived chemokine (MDC).
However, controversy arises when the in vivo significance of this distinct expression is discussed.
To address the functional role of CCR3/eotaxin and CCR4/MDC during the in vivo recruit-
ment of Th2 cells, we have transferred effector Th cells into naive mice to induce allergic airway
disease. Tracking of these cells after repeated antigen challenge has established that both CCR3/
eotaxin and CCR4/MDC axes contribute to the recruitment of Th2 cells to the lung, demon-
strating the in vivo relevance of the expression of these receptors on Th2 cells. We have shown
that involvement of the CCR3/eotaxin pathway is confined to early stages of the response in
vivo, whereas repeated antigen stimulation results in the predominant use of the CCR4/MDC
pathway. We propose that effector Th2 cells respond to both CCR3/eotaxin and CCR4/MDC
pathways initially, but that a progressive increase in CCR4-positive cells results in the predomi-
nance of the CCR4/MDC axis in the long-term recruitment of Th2 cells in vivo.
Key words: chemokines • effector T helper type 2 cells • migration • allergic airway disease • 
chemokine receptors
 
Introduction
 
T cells are critical mediators of inflammation, and as such
their migration to inflammatory sites is a tightly controlled
process involving a complex series of molecules expressed
by a variety of cell types. This results in the delivery of func-
tional subsets of cells to particular tissues or microenviron-
ments. This is especially important for T cells, since effector
T cells can be divided into distinct subsets based on their
cytokine profiles and functional properties. Th1 cells char-
acteristically produce IFN-
 
g
 
 and contribute to host defense
against pathogens, whereas Th2 cells produce IL-4 and IL-5
and are associated with allergic reactions involving IgE,
eosinophils, and basophils (1). Th2 cells and the cytokines
they secrete are thought to be critically important for the
development of injury during allergic reactions such as
asthma. However, it is unclear how or why the Th2 subset
migrates to the lung. Th2 cells have previously been distin-
guished from Th1 cells by virtue of their cytokine profile,
although more recently a range of surface markers specific
for Th2 cells has been defined (2, 3). Of particular impor-
tance to the question of selective Th subset migration to
inflammation sites is the growing evidence that chemokine
receptor expression is tightly regulated on Th cells, and that
Th cell subsets express restricted receptors for chemokines
(4). In accordance with this selective expression, Th1 and
Th2 cells differentially migrate in response to the chemo-
kines that bind to these receptors.
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Eotaxin and monocyte-derived chemokine (MDC)
 
1
 
 are
among the chemokines that seem to attract selectively Th2
but not Th1 cells (5, 6). Eotaxin is produced by epithelial
cells and binds CC chemokine receptor (CCR)3 with high
affinity and fidelity (7–9), whereas MDC is produced by
macrophages and interacts specifically with CCR4 (10).
CCR3 was originally described on eosinophils and baso-
phils (8, 9), but has been documented as being present on
human Th2 but not Th1 cells (5, 6). The fact that this par-
ticular Th cell subset expresses the receptor for a proeosino-
philic chemokine is interesting in the context of the patho-
physiology of allergic lung disease. The attraction of these
Th2 cells by eotaxin may represent a mechanism by which
an allergen-driven reaction escalates with the production of
IL-4 and IL-5, both of which are necessary for the differen-
tiation and activation of eosinophils. CCR4 has been simi-
larly identified as a Th2-specific marker (11, 6), and its
ligands, MDC and thymus and activation-regulated chemo-
kine (TARC), have been shown to attract Th2 cells in pref-
erence to Th1 cells (6, 11–13). CCR8 is also selectively ex-
pressed on Th2 cells (14). Several groups have used T cells,
either directly isolated from patients or generated in vitro, to
show elegantly that CCR3 and CCR4 identify a subset of
human T cells that exhibit a cytokine profile consistent with
that of Th2 cells. However, the role of the CCR3/eotaxin
or CCR4/MDC axes in attracting effector Th2 cells has not
been established during in vivo
 
 
 
inflammatory processes.
The aim of this study was to determine the functional im-
portance of the eotaxin/CCR3 and MDC/CCR4 axes on
the migration of antigen-specific Th2 cells
 
 
 
in vivo using a T
cell transfer model of allergen-induced lung injury in mice.
We have used this in vivo model to show that eotaxin/
CCR3 and MDC/CCR4 interactions play a critical, coop-
erative role in the homing of antigen-specific Th2 cells to
the challenged lung, giving rise to eosinophilia and bronchial
hyperresponsiveness (BHR). Moreover, we have deter-
mined that eotaxin/CCR3-mediated recruitment of Th2
cells in vivo is transient and progresses to an MDC/CCR4-
dominated response that is maintained over time.
 
Materials and Methods
 
Mice. 
 
Mice expressing the transgene for the DO11.10
TCR-
 
a
 
/
 
b
 
, which recognizes residues 323–339 of chicken OVA
in association with I-Ad, were provided by Dr. D. Loh (Wash-
ington University, St. Louis, MO [15]). Transfer recipients were
6–8-wk-old female BALB/cJ mice (The Jackson Laboratory).
 
In Vitro Polarization of T Cells. 
 
OVA-specific TCR-transgenic
CD4
 
1
 
 T cells were isolated from the spleen and cultured in com-
plete RPMI 1640 medium with OVA323–339 (1 
 
m
 
g/ml) and
mitomycin C–treated splenocytes. For Th1 phenotype develop-
ment, recombinant murine IL-12 (40 ng/ml; Endogen) and neu-
tralizing anti–IL-4 Ab (11B11, 20 
 
m
 
g/ml; R&D Systems) were
added; for Th2 phenotype development, recombinant murine
IL-4 (50 ng/ml) and anti–IL-12 (TOSH-2, 10 
 
m
 
g/ml; Endogen)
were used. Cells were cultured for three rounds of antigenic
stimulation under polarizing conditions. At this point, the cells
were divided into two portions, with the majority being used to
induce pulmonary inflammation as described below. A small sam-
ple (2 
 
3
 
 10
 
5
 
 cells) from each culture was activated on immobi-
lized anti-CD3 mAb (2C11, 10 
 
m
 
g/ml; PharMingen) in the pres-
ence of human (h)IL-2 (10 U/ml; Endogen) for 48 h to determine
the integrity of the polarization. Culture supernatants were col-
lected for measurement of IL-4, IL-5, and IFN-
 
g
 
 levels by ELISA
(Endogen), and cell pellets were collected for RNA extraction
and PCR analysis. Th2 cells produced high IL-4 and IL-5 levels
but little IFN-
 
g
 
, whereas Th1 cells produced high IFN-
 
g
 
 levels
but little IL-4 and IL-5 (Th2 cells: 100–300 ng/ml IL-4, 50–150
ng/ml IL-5, and 
 
,
 
20 pg/ml IFN-
 
g
 
; Th1 cells: 7,000–15,000 ng/
ml IFN-
 
g
 
). Similarly, RNA expression analysis revealed that Th2
cells expressed predominantly IL-4 and IL-5 but little if any IFN-
 
g
 
,
whereas the reverse was true of Th1 cells.
 
Induction of Pulmonary Inflammation. 
 
In preparation for induc-
tion of allergic inflammation, Th1 or Th2 cells produced as de-
scribed above were rested in hIL-2 (10 U/ml; Endogen) for 48 h
before being washed in tissue culture medium. Recipient BALB/c
mice were given 2 
 
3
 
 10
 
6
 
 cells intravenously. 24 h later, mice
were exposed to an aerosol of OVA (50 mg/ml, Grade V; Sigma
Chemical Co.) for 20 min. Thereafter, mice were challenged
daily and were killed 24 h after the last aeroallergen challenge on
day 4, 7, or 14. Control mice received cells but were challenged
with aerosolized PBS. After the mice were killed, bronchoalveo-
lar lavage (BAL) was collected by cannulation of the trachea and
lavage with 1 ml of PBS. Lungs were then inflated with optimum
cutting temperature (OCT) compound and removed, and the
right lobes of the lung were snap-frozen in liquid nitrogen while
the left were fixed in 10% buffered formalin.
For blocking studies, mice were injected daily with 100 
 
m
 
g per
mouse polyclonal rabbit antieotaxin Abs (7) or polyclonal rabbit
anti–murine MDC (13) 30 min before OVA challenge. Mice were
then killed at day 4 after T cell transfer (after three antigen chal-
lenges) or at day 7 (after six antigen challenges), as shown in Fig. 1.
 
Determination of BHR. 
 
Airway responsiveness was measured
in Th2 recipient mice 24 h after the last aerosol challenge by re-
cording respiratory pressure curves using whole body plethys-
mography (Buxco; EMKA Technologies) in response to inhaled
methacholine (Sigma Chemical Co.) at concentrations ranging
from 2.5 to 25 mg/ml for 1 min. Airway responsiveness was ex-
pressed in enhanced pause (
 
P
 
enh
 
), a calculated value that correlates
with measurement of airway resistance, impedance, and intra-
pleural pressure in the same mouse: 
 
P
 
enh
 
 
 
5 
 
(
 
t
 
e
 
/
 
t
 
r1
 
) 
 
3
 
 Pef/Pif (
 
t
 
e
 
,
expiration time; 
 
t
 
r
 
, relaxation time; Pef, peak expiratory flow; Pif,
peak inspiratory flow).
 
BAL.
 
Total BAL cells were counted, and aliquots (5 
 
3
 
 10
 
5
 
cells per slide) were pelleted onto glass slides by cytocentrifugation.
A differential cell count was then performed after Wright-Giemsa
staining (Fisher Diagnostics). Percentages of eosinophils, lympho-
cytes, neutrophils, and macrophages were determined by counting
in eight randomly selected high-power fields (hpf; magnification:
 
3
 
40; total area: 0.5 mm
 
2
 
) and dividing this number by the total
number of cells per hpf. To obtain the absolute number of each
leukocyte subtype in the lavage, these percentages were multiplied
by the total number of cells recovered from the BAL fluid.
 
In Vivo Measurement of Cytokine Production. 
 
Levels of the cyto-
kines IL-4, IL-5, IFN-
 
g
 
, IL-6, and IL-10 were determined in the
lavage fluid of mice using ELISA kits (Endogen).
 
1
 
Abbreviations used in this paper:
 
 AAD, allergic airway disease; BAL, bron-
choalveolar lavage; BHR, bronchial hyperresponsiveness; CCR, CC
chemokine receptor; hpf, high-power field(s); MDC, monocyte-derived
chemokine; 
 
P
 
enh
 
, enhanced pause; TARC, thymus and activation-regu-
lated chemokine. 
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Figure 1. Adoptive transfer of Th effector cells leads to
AAD. BALB/c mice were injected with 2 3 106 cells fol-
lowed by daily aerosolized OVA. Mice were killed on day
4 or 7 for analysis. Results shown are from two different
experiments with five mice per group for each experi-
ment. (A, i) Total leukocytes were recovered from BAL,
counted, and cytospun, and differential counts were calcu-
lated. Total numbers of eosinophils (black bars) and neu-
trophils (white bars) are shown for days 4 (left) and 7
(right) after transfer of Th1 (gray background throughout
figure) or Th2 cells (white background throughout fig-
ure). (A, ii) The percentage of eosinophils (black bars) and
neutrophils (white bars) within peribronchiolar infiltrates
was counted on days 4 (left) and 7 (right) after transfer of
either Th1 or Th2 cells. (A, iii) Representative sections
from mice transferred with Th1 cells (a and c) or Th2 cells
(b and d) stained with eosinophil peroxidase (a and b) or
chloroacetate esterase (c and d) to show the presence of
eosinophils or neutrophils, respectively (original magnifi-
cations: 3400; [inset] 31,000). (A, iv) BHR was mea-
sured after provocation with 20 mg/ml methacholine at
days 4 and 7. Bars show mean Penh (6 SEM) of groups of
five mice before (gray bars) or after (white bars) metha-
choline stimulation. (B) BAL cytokines were measured by ELISA in OVA- (gray bars) and PBS-challenged mice (white bars) after transfer of Th1 (gray
panel) or Th2 cells (white panel). Each bar represents the mean (6 SEM) concentration in groups of five mice on day 4. 
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Measurement of Chemokine Ligand and Receptor Expression by PCR
Analysis.
 
PCR was performed using the Advantage
 
®
 
 KlenTaq
polymerase (Clontech Laboratories) according to the manufac-
turer’s instructions. cDNA derived from 25 ng of total RNA was
used for each 30-
 
m
 
l reaction containing 0.5 
 
m
 
M primers, 0.2 mM
dNTP mix, 1
 
3
 
 PCR reaction buffer, and 0.5 
 
m
 
l polymerase.
Samples were amplified at 94
 
8
 
C for 30 s, 52–60
 
8
 
C for 1 min, and
68
 
8
 
C for 1 min for 20, 25, or 32 cycles. 10 
 
m
 
l of each reaction
was loaded per well on 1.5% agarose gels. Primer sequences were
as follows: for CCR3, 5
 
9
 
-TCTGTGGAATGAGTGGGGTT-
TTG and 5
 
9
 
-GTAATACGACTCACTATAGGGACTTCTG-
GATAGCGAGGACTG; for CCR4, 5
 
9
 
-ATCGTGCACGCG-
GTATTCTCC and 5
 
9
 
-GACGGGGTTAAGGCAGCAGTGA;
for MDC, 5
 
9
 
-GGTGAAGAAGCTACTCCATAAACT and 5
 
9
 
-
GTAATACGACTCACTATAGGGAGAAGGGATAGAGGG-
GAGGTA; and for eotaxin, 5
 
9
 
-TCTCCCTCCACCATGCAGAG
and 5
 
9
 
-CAGATCTCTTTGCCCAACCT. The glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) primers were purchased
from Clontech Laboratories.
 
Lung Histology and Immunohistochemistry. 
 
The left lobe of the
lungs was fixed in 10% neutral buffered formalin (NBF; J.T.
Baker) and paraffin embedded. Sections (4 
 
m
 
m) were stained for
cyanide-resistant peroxidase according to standard protocols (16),
then counterstained with hematoxylin to depict eosinophils or
with chloroacetate esterase to show neutrophils. The composi-
tion of infiltrates was then determined by counting the total
number of infiltrating cells in five peribronchiolar fields and de-
termining the percentage of eosinophils, neutrophils, and mono-
nuclear cells. General morphology was assessed on hematoxylin
and eosin–stained sections.
For determination of antigen-specific T cells within lung tissue,
serial frozen sections (4 
 
m
 
m) were stained with either anti-CD4
(PharMingen) or an Ab specific for the transgenic TCR, KJ126
(17). Both of these Abs were biotinylated, and positive staining was
detected using streptavidin-peroxidase (DAKO Corp.) followed by
diaminobenzidine (DAB; Vector) before counterstaining in hema-
toxylin. Eosinophils were stained for cyanide-resistant peroxidase
as described above.
The number of cells per hpf was obtained by counting posi-
tively stained cells (CD4 cells or eosinophils) in five fields per sec-
tion at a magnification of 400. To calculate the percentage of
KJ126
 
1 
 
CD4 cells, CD4 cells were counted; the same field was
located on the KJ126-stained serial section, and positive cells were
enumerated. At least 250 CD4 cells were counted for each section,
and the percentage of KJ126
 
1 
 
CD4 cells was then calculated.
CCR3
 
1
 
 or CCR4
 
1
 
 Th2 cells were detected in lung sections
by immunohistochemical staining using polyclonal Abs specific
for the COOH terminus of CCR3 or CCR4 (Santa Cruz Bio-
technology). Staining of primary Abs was visualized with a biotin-
ylated donkey anti–goat Ig Ab (Jackson Immunochemicals) fol-
lowed by streptavidin-peroxidase as described above. Positively
stained Th2 cells were enumerated by locating an infiltrate in the
serial KJ126-stained section and counting the percentage of KJ-
stained cells that were either CCR3
 
1
 
 or CCR4
 
1
 
. At least 50
KJ126-stained cells were counted in each section from lungs ob-
tained at days 4 (
 
n
 
 5 
 
6), 7 (
 
n
 
 5 
 
4), and 14 (
 
n
 
 5 
 
4), with between
two and three lobes stained per mouse.
 
Results and Discussion
 
Adoptive Transfer of Th Effector Cells Leads to Allergic Air-
way Disease. 
 
The evaluation of the role of chemokines in
the migration of Th2 cells in vivo during active immunization
models of allergic airway disease (AAD) is complicated by the
difficulty of tracking a small subset of effector Th2 cells that are
specific for antigen during the course of the inflammatory re-
sponse. To evaluate the role of the eotaxin and MDC chemo-
tactic pathways in vivo, we sought a mouse model in which
basic pathophysiological features of AAD (eosinophilia, inter-
stitial inflammation, bronchial hyperresponsiveness, and cyto-
kine production) could be induced in vivo upon transfer of
well-characterized, easy-to-track, antigen-specific Th2 cells.
Such an approach would enable us technically to address the
hypothesis mentioned above, but interpretation of the results
obtained would necessarily have to consider the clear differ-
ences and limitations of the experimental system chosen. Spe-
cifically, a mouse model system in which some of the impor-
tant processes during the development of an AAD-type
chronic inflammatory reaction are totally or partially “by-
passed,” whereas others (i.e., the migration, accumulation, and
activation of Th2 cells to the airways and the pathophysiolo-
gies they elicit) are presumably maintained. Therefore, it is
important to recognize when interpreting the data presented
in this report that antigen presentation, antigen-presenting cell
activation and migration, and activation, migration, and differ-
entiation of naive T cells and that of their immature effector
Th descendants, among others, are essential processes that
most likely occur and progress differently in adoptive transfer
models and active immunization models of AAD.
Several elegant models of AAD have been described
whereby transfer of in vitro–polarized Th2 cells induces pul-
monary eosinophilia (18–21). However, the Th cells used
for these studies were, in general, polarized for short times in
culture. Therefore, we set out to develop a system whereby
Th cells were maximally polarized to ensure differential che-
mokine receptor expression, and thus induced multiple
pathophysiological endpoints after transfer in vivo. Th2 or
Th1 cells were generated in vitro after several rounds of
polarizing cytokines before transfer in vivo, when mice re-
ceived multiple serial in vivo antigen challenges. Accord-
ingly, Th1 or Th2 cells were transferred intravenously to
unsensitized BALB/c recipient mice, and changes in lung
function were measured at various time intervals after anti-
gen challenge. Mice were then killed at day 4 or 7, and the
extent of inflammation was determined in the BAL and tis-
sue (Fig. 1). Control mice that received cells but no antigen
challenge showed no increase in cells either in the BAL or
the tissue. Transfer of either Th1 or Th2 cells in conjunc-
tion with serial OVA challenge resulted in an increase in
the total number of lavage leukocytes, as has been reported
previously using similar protocols (18, 21). Staining of cyto-
spins revealed a differential migration of leukocytes to BAL
after Th2 transfer compared with Th1 transfer, in that trans-
fer of Th2 cells initiated an eosinophilic infiltrate, whereas
Th1 transfer initiated a neutrophilic infiltrate. Infiltration
increased with challenge, peaking at day 7 (Fig. 1 A, i). Simi-
lar results were observed in lung tissue, in which Th1 trans-
fer resulted in a perivascular and peribronchiolar infiltrate,
composed largely of neutrophils, in conjunction with mac-
rophages and lymphocytes. Conversely, Th2 transfer initiated 
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an eosinophilic infiltration to perivascular and peribronchi-
olar areas (Fig. 1 A, ii). The proportion of either eosinophils
or neutrophils was 35% after Th2 cell transfer and 25% after
Th1 cell transfer, respectively (Fig. 1 A, iii). Interestingly,
this induction of pulmonary inflammation after transfer of
antigen-specific Th2 cells was accompanied by a correspond-
ing increase in BHR (Fig. 1 A, iv), although no such change
was detected after Th1 cell administration. The polarized
pathological response to transfer of Th1 or Th2 cells was re-
flected in the repertoire of cytokines in BAL fluid. Th1 cell
transfer induced secretion of IFN-
 
g
 
 but low levels of IL-4,
-5, -10, and -13, whereas Th2 transfer was associated with
an increase in IL-4, -5, -6, -10, and -13, with no discernible
increase in IFN-
 
g
 
 (Fig. 1 B, i).
 
Th2 Cells Preferentially Express CCR3 and CCR4 In Vivo
As Well As In Vitro.
 
Recent evidence has shown that ef-
fector Th cells are polarized with respect to their chemo-
kine receptor expression as well as their cytokine produc-
tion, and that Th2 cells preferentially express CCR3 and
CCR4 (5, 6, 11). These findings were first confirmed in
the murine in vitro–polarized Th cells used for this study.
Th2 cells showed increased expression of CCR3 and CCR4
RNA after activation with anti-CD3 and IL-2 (Fig. 2 A).
The increased expression of CCR3 after activation corre-
lates well with an enhanced calcium-mobilization response
to eotaxin stimulation on mouse activated Th2 cells (not
shown) compared with nonactivated control cells. This is
somewhat unexpected, as anti-CD3 stimulation, in contrast
to CCR4, downregulates CCR3 expression in human Th2
cells (14). This difference could reflect a disparity between
the mouse and the human system, or simply represent a dif-
ferent degree of differentiation/activation between the cells
used in the experiments described here and those used by
other investigators. Immunohistochemical staining for CCR3
and CCR4 showed that the majority of the cells were dou-
ble positive after incubation with Th2-polarizing cytokines
(Fig. 2 B), but not with Th1 cytokines (data not shown).
With this protocol, all cells expressed both receptors simulta-
neously, although there was a variation in the degree of ex-
pression, with definite high and low expressing populations.
The decision concerning the activation state of the Th2
cells to be transferred in vivo is one that deserves comment.
Different groups have used different conditions to polarize
and activate Th2 cells before transfer in vivo (18–21). In
general, these protocols are based on the transfer of Th cells
that are polarized for short times in culture. In the system
used here, Th cells were maximally polarized and activated
to ensure differential chemokine receptor expression. A sec-
ond reason for the degree of polarization and activation
used here was to ensure the induction of multiple patho-
physiological endpoints after transfer in vivo. When inter-
preting the results obtained in this report and comparing
them with results obtained in others, it is critical to factor
in and to compare such possible differences in activation
and polarization of the transferred T cells, which could well
represent different stages of disease initiation and progression
and/or the cellular basis of different etiologies resulting in
the same final chain of pathophysiological events.
To determine the expression pattern of CCR3 and CCR4
and their ligands in lung tissue after adoptive transfer, we per-
formed PCR in pools of mRNA extracted from lungs at
days 4 and 7 after Th cell transfer. We found that CCR3
and its ligand, eotaxin, are upregulated in lung RNA iso-
lated after serial OVA challenge of mice after Th2 cell
transfer, but not after Th1 transfer (Fig. 2 C). Higher CCR4
mRNA levels were also seen in mice after Th2 cell transfer
compared with Th1 transfer. MDC mRNA was expressed
after challenge in both Th1 and Th2 recipient mice, pre-
sumably since the main cell type producing this chemokine
is the macrophage (10). We did not find any significant
TARC expression after induction of pulmonary inflamma-
tion (data not shown); thus, MDC was used as the ligand
for functional studies. The principal site of CCR3 expres-
sion is likely to be on eosinophils, and of CCR4 on mac-
rophages, but these receptors have also been found on Th2
cells in vitro (5, 11).
To localize the expression of CCR3 and CCR4 with Th2
cells in vivo, we used immunohistochemical staining to de-
termine that both CCR3
 
1
 
 and CCR4
 
1
 
 Th2 cells were in-
deed present in the lung after intravenous transfer of antigen-
specific Th2 cells and subsequent allergen challenge (Fig.
2 D). Moreover, there was a greater proportion of Th2 cells
that expressed CCR3 rather than CCR4 on day 4, whereas
the converse was true for day 7, with a greater proportion of
Th2 cells expressing CCR4 rather than CCR3 (Fig. 2 D).
There were no CCR3- or CCR4-expressing effector Th cells
after transfer of Th1 cells (data not shown). When this analy-
sis was performed at day 14 (after 13 in vivo antigen stimula-
tions), the vast majority (
 
.
 
95%) of Th2 cells found in the
lung expressed CCR4, whereas there were only a small
number (
 
,
 
5%) of CCR3-expressing Th2 cells (Fig. 2 D).
 
CCR3/Eotaxin and CCR4/MDC Function in a Coordinated
Manner to Promote Th2 Cell Recruitment In Vivo.
 
Based on this
differential expression of CCR3 and CCR4, we formu-
lated the hypothesis that CCR3/eotaxin and CCR4/MDC
pathways play differential, coordinating roles in the devel-
opment of pathology during allergic reactions. To test this
hypothesis, we used neutralizing Abs to block the ligands
for CCR3 and CCR4, eotaxin and murine MDC, respec-
tively, after acute or repeated antigen challenge in mice in-
jected with antigen-specific Th cells. It should be kept in
mind that, although eotaxin is the main described ligand
for CCR3 in both mice and humans, other chemokines
such as monocyte chemoattractant protein 3 (MCP-3) have
been shown to exert their effects in vitro at least partially
through CCR3 binding. Similarly, TARC is yet another
known ligand for CCR4. Therefore, blockage of eotaxin
and MDC might not necessarily be equivalent to blockage
of CCR3 or CCR4.
We have found previously that the antieotaxin and anti-
MDC Abs used in this study block the specific migration of
CCR3- or CCR4-expressing cells, both in vitro and in
vivo (7, 13). Mice were killed on day 4 or 7, and the migra-
tion of antigen-specific Th cells to the lung was determined
histologically. The donor Th1 and Th2 cells expressed a clo-
notypic TCR recognized by an mAb, making it possible to 
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distinguish donor (antigen-specific) cells from host Th cells
(17). We found that although the total number of CD4
cells was unaffected by blockage of either CCR3 or CCR4
ligands, the percentage of antigen-specific Th2 cells decreased
by at least 50% (Fig. 3). In contrast, blockage of eotaxin or
MDC had no effect on the migration of antigen-specific
Th1 cells (Fig. 3 B). However, the specific effect of block-
ing one pathway versus the other differed at each time
point (as discussed in detail below). These data show that
eotaxin and MDC interactions with their specific receptors
in vivo are critical for antigen-specific Th2 cell recruitment
to the lung in this model.
To determine whether this selective blockage of anti-
gen-specific Th cells by distinct chemokines affected eosin-
ophil infiltration, BHR, and BAL cytokine production, we
measured these parameters on day 4 after blockage with an-
tieotaxin, or on day 7 after neutralization of MDC. Eosin-
ophilia was decreased by blockage of either eotaxin or MDC
(Fig. 4 A). This may stem from interference in the interac-
tion of eotaxin with CCR3 on eosinophils, but also with
CCR3 on Th2 cells, since the initiating event in eosinophil
accumulation in this model occurs as a direct result of anti-
gen-specific Th2 cell migration. BHR was also reduced af-
ter blockage of either eotaxin or MDC (although the latter
did not reach statistical significance; Fig. 4 B). The de-
creased migration of antigen-specific Th cells also impaired
the production of Th2-type cytokines, with significant de-
creases in IL-4 after blockage of eotaxin or MDC (Fig. 4
C). Neither treatment had any effect on IL-5 production.
These results demonstrate unequivocally that Th2 cells
alone can initiate pulmonary inflammation and that the re-
cruitment of these essential cells via the CCR3/eotaxin
(day 4) and CCR4/MDC (day 7) pathway is a critical
event in the development of AAD. In this regard, it is im-
portant to note that eosinophilia and BHR were only
moderately reduced (
 
z
 
35% inhibition of eosinophilia; data
Figure 2. Chemokine receptor expression in
donor Th cell populations, and in lungs after
Th cell transfer. (A) Expression of chemokine
receptors CCR3 and CCR4 and their respec-
tive ligands, eotaxin and MDC, were deter-
mined by PCR in effector Th cells after three
rounds of polarization and activation with anti-
CD3 Ab. Polarity of Th cells was checked by
expression of IL-5 and IFN-g in each popula-
tion. (B) Protein expression of CCR3 and
CCR4 was confirmed by immunohistochemi-
cal staining of cytospins prepared from third-
round polarized cells. (C) Expression of
chemokine receptors CCR3 and CCR4 and
their respective ligands, eotaxin and MDC, was
determined by PCR in lung RNA pooled
from three mice transferred with either Th1 or
Th2 cells and challenged with PBS or OVA.
Levels were compared with those of the house-
keeping gene, GAPDH. (D) Relative propor-
tions of CCR31 and CCR41 Th2 cells in
allergic lung tissue. CCR3- and CCR4-express-
ing Th2 cells were enumerated by locating an
infiltrate in each KJ126-stained section and
counting the percentage of KJ126-stained cells
that were either CCR31 or CCR41 in serial sec-
tions. Sections were counted in lungs obtained
at day 4 (n 5 6), 7 (n 5 4), or 14 (n 5 5).271 Lloyd et al.
not shown) on day 7 after blockage of eotaxin (compared
with z75% inhibition of eosinophilia at day 4; Fig 4), indi-
cating that other chemokines in addition to eotaxin partici-
pate in the final recruitment of eosinophils in vivo (data not
shown).
The CCR4/MDC Axis Is Dominant in Mediating Recruit-
ment of Th2 Cells after Repeated Allergen Exposure.  We have
shown that CCR3/eotaxin and CCR4/MDC mediate se-
lective recruitment of antigen-specific Th cells during the
allergic process. However, our results also show that these
axes are important at different stages of the disease process.
In our model, the CCR3/eotaxin pathway was critical in
mediating the recruitment of Th2 cells after initial antigen
stimulation in vivo, as determined by effective blockage at
day 4. However, after repeated antigen stimulation (on day
7), the CCR3/eotaxin axis was superceded by the CCR4/
MDC pathway, which was critical for Th2 migration by
day 7. Further stimulation with antigen results in .95% of
Th2 cells expressing CCR4 by day 14, but ,5% expressing
CCR3. This reinforces the view that chemokines and their
receptors function in a tightly controlled, coordinated man-
ner, as has been suggested in active immunization models
of pulmonary inflammation (22). The interpretation of the
results reported here in the context of the pattern of eo-
taxin and MDC expression in the lung during the develop-
ment of AAD after active immunization (13) illustrates the
complexity of hypothesizing expression and function cor-
relations. For example, we have reported previously that
the peak of MDC expression precedes that of eotaxin ex-
pression during the course of an active immunization model
of AAD (13). Based on the results reported here, we pro-
pose that this maximal accumulation of MDC mRNA and
protein probably correlates more with an early accumula-
tion of monocytes/macrophages (which produce signifi-
cant amounts of MDC [13]) in the lung in that particular
model than with an early recruitment of Th2 cells. We hy-
pothesize that lower levels of MDC present at later time
points (13) are in turn critical for the recruitment of Th2
cells to the airways. Conversely, we hypothesize that maxi-
mal levels of eotaxin occurring at later time points during the
course of the same active immunization models (7, 13) cor-
relate better with final eosinophil recruitment, whereas
lower levels of eotaxin present in the lung at early time
points could be key to initiate Th2 accumulation in the lung.
The data presented here also strengthen the hypothesis
that Th cells modulate their chemokine receptor expression
according to the degree and extent of antigen stimulation
and the cytokine milieu. Our experiments indicate that this
indeed occurs during the in vivo allergic response. More-
over, our results show that this regulation of expression
gives rise to functional consequences. These results are aligned
with the data from in vitro experiments that show that Th2
cells lose CCR3 expression and preferentially gain CCR4
expression in response to repeated antigen stimulation (14).
Concluding Remarks. We have taken advantage of a
mouse model of AAD based on the adoptive transfer of po-
larized effector Th cells to determine the functional impor-
tance of the chemokine receptor/ligand axes CCR3/eo-
Figure 3. CCR3/eotaxin and CCR4/MDC function in a co-
ordinated manner to promote Th2 cell recruitment in vivo. Num-
bers of total CD4 cells and antigen-specific donor Th cells were
counted in mice treated with neutralizing Ab (stippled bars) or
control Ab (white bars) after transfer of Th2 (A) or Th1 (B) cells.
The percentage of antigen-specific cells was quantified by count-
ing at least 250 CD41 cells in each section, and then counting the number of KJ1261 cells in serial sections at a magnification of 400 for 10 mice in each
group from two separate experiments (i). Total numbers of CD41 cells per hpf are shown (ii).272 CCR3/Eotaxin and CCR4/MDC Mediate Th2 Recruitment to the Lung
taxin and CCR4/MDC in mediating the recruitment of
antigen-specific Th2 cells during in vivo allergic reactions.
We have shown that both eotaxin/CCR3 and MDC/
CCR4 play a critical role in the homing of Th2 cells to the
lung after antigen challenge. This finding emphasizes the
relevance of previous in vitro results and demonstrates for
the first time in vivo that CCR3 and CCR4 not only are
markers of Th2 cells, but also have a critical pathophysio-
logical significance in the development of AAD (as deter-
mined by their impact in BHR and eosinophilia). More-
over, we have determined that these pathways act in a
coordinated cooperative manner, with the CCR3/eotaxin
pathway being critical in the acute stages of a response after
initial challenge. However, repeated antigen challenge re-
sults in an increased frequency of CCR4-expressing Th2
cells. Consequently, the CCR4/MDC pathway ultimately
dominates in the recruitment of antigen-specific Th2 cells.
Based on these findings, we would like to propose that it is
the CCR4/MDC axis which is primarily responsible for
the long-term recruitment of antigen-specific Th2 cells to
target organs, such as airways, during chronic inflammatory
responses in which there is repeated exposure to allergen.
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